Exclusive

Publication

Byline

Killer: గుప్పెడంత మనసు జ్యోతి పూర్వజ్ హీరోయిన్‌గా కిల్లర్- క్రిస్టోఫర్ నోలన్ ఒడిస్సీతో పోల్చారన్న దర్శకుడు,నటుడు పూర్వజ్

భారతదేశం, అక్టోబర్ 27 -- Director Poorvaj About Jyothi Poorvaj Killer Movie: స్టార్ మాలో సూపర్ హిట్‌గా దూసుకుపోయిన గుప్పెడంత మనసు సీరియల్‌లో జగతిగా అలరించిన నటి జ్యోతి పూర్వజ్ హీరోయిన్‌గా నటించిన లేటె... Read More


Summit Securities (New) to declare Quarterly Results

Mumbai, Oct. 27 -- Summit Securities (New) will hold a meeting of the Board of Directors of the Company on 3 November 2026. Published by HT Digital Content Services with permission from Capital Marke... Read More


Narmada Agrobase to discuss results

Mumbai, Oct. 27 -- Narmada Agrobase will hold a meeting of the Board of Directors of the Company on 2 November 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More


Sahajanand Medical Techs. to convene board meeting

Mumbai, Oct. 27 -- Sahajanand Medical Techs. will hold a meeting of the Board of Directors of the Company on 5 November 2026. Published by HT Digital Content Services with permission from Capital Mar... Read More


Palm Jewels announces board meeting date

Mumbai, Oct. 27 -- Palm Jewels will hold a meeting of the Board of Directors of the Company on 30 October 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More


Love is in the air, and so is the bill: 13pc of Malaysian men willing to go into debt for dates

KUALA LUMPUR, Oct. 27 -- For some Malaysian men, keeping the romance alive could mean stretching their wallets - and a new study suggests some are even willing to go into debt for a date. According t... Read More


Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... Read More


Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... Read More